Latest stories on STTK
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday
Yahoo Finance61 · neutralanalyst
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday
The Motley Fool61 · neutralanalyst
JPMorgan reiterates Shattuck Labs stock rating on DR3 program
Investing.com Analyst Ratings56 · neutralanalyst
Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline Update - Slideshow
Seeking Alpha50 · neutralgeneral
Shattuck Labs drops 6%, prices $75M share raise at $4 per share
Seeking Alpha24 · bearishgeneral
Shattuck Labs: "Hold" On Phase 1 SL-325 Data And Next Stage Of Development
Seeking Alpha56 · neutralproduct/pr
Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering | STTK Stock News
StockTitan24 · bearishgeneral
Shattuck Labs Reports Promising Phase 1 Data for SL-325
TipRanks67 · bullishproduct/pr
Shattuck Labs, Inc. (STTK) files 8-K
SEC 8-K50 · neutralgeneral
Shattuck Labs launches proposed public offering of common stock
Seeking Alpha24 · bearishgeneral
Shattuck Labs, Inc. Announces Proposed Public Offering | STTK Stock News
StockTitan24 · bearishgeneral
Shattuck Labs secures $54.9M from warrant exercises, extends cash runway into 2029
Seeking Alpha28 · bearishgeneral
Shattuck Labs, Inc. (STTK) Discusses Phase I Results for DR3 Blocking Antibody SL-325 and Pipeline Update Transcript
Seeking Alpha59 · neutralproduct/pr
SL-325 Shows Promising Safety and Durability in Phase 1, Setting Stage for Crohn’s Disease Trial
MarketChameleon67 · bullishproduct/pr
Shattuck Labs Announces Phase 1 Results for SL-325 | STTK Stock News
StockTitan63 · neutralproduct/pr
Shattuck Labs: Priced As If Risk Was Not A Part Of The Equation
Seeking Alpha38 · neutralgeneral